5 Best BioTech Companies to Watch 2023
The Silicon Review
| Company | Management | Description |
| Gubra www.gubra.dk |
Henrik Blou, CEO |
Gubra is a privately-held biotech company with two primary areas of business: Pre-clinical contract research services and proprietary early target and drug discovery programs. Its focus is the metabolic space where it specializes in in vivo pharmacology, peptide chemistry, molecular pharmacology, histology, 3D imaging, stereology, NGS (next generation sequencing), bioinformatics and ex vivo assays. |
| Celmatix www.celmatix.com |
Piraye Yurttas Beim, PhD, Founder & CEO |
Celmatix Inc. is a preclinical-stage women’s health biotech focused uniquely on ovarian biology. It is addressing areas of high unmet need by developing the next generation of interventions and pioneering advancements in ovarian health. |
| Turn Biotechnologies www.turn.bio |
Anja Krammer, CEO & Vittorio Sebastiano, Co-Founder, Head of Research |
Turn Biotechnologies develops mRNA medicines that induce the body to heal itself by instructing specific cells to fight disease or repair damaged tissue. It is focused on reprogramming the epigenome – a network of chemical compounds and proteins that control cell functions by influencing which genes are active – to restore capabilities that are often lost with age. |
| Strateos strateos.com |
Mark Fischer-Colbrie, President & CEO |
Strateos is a pioneer in the development of remote access laboratories and lab control software for life science discovery. Its mission is to create new knowledge driven by data, computation, automation, and high-throughput robotics with the goal of fundamentally advancing the life sciences. |
| Consonance consonance.tech |
Mariusz Mąsior, CEO |
Consonance is a medical device development company focused on medical device product development for startups, Medtech companies and pharma multinationals. |
MOST VIEWED ARTICLES
RECOMMENDED NEWS
TOP NEWS
YOU MAY ALSO LIKE
